Forvard P/S multiplikatori: Helius Medical Technologies, Inc. (HSDT)
Helius Medical (HSDT) skleroz terapiyasi uchun noyob neyromodulyatorlarni ishlab chiqadi va barqaror marjalarni saqlash uchun optimallashtirilgan distribyutsiya tarmog'idan foydalanadi. Forward P/S ko'rsatkichi kelajakdagi sotuvlarga nisbatan fundamental baholash tendentsiyasini namoyish etadi va ushbu qiymat 7.30 darajasida qat'iy belgilangan. Biznesning o'sishi AQSHda sug'urta to'lovlarining kengayishi bilan bog'liq bo'lib, bu kompaniyani umumiy makroiqtisodiy tebranishlardan mustaqil qiladi.
heliusmedical.com (HSDT) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari
- bozor narxi va tahlilchilarning maqsadli narxlari:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
- emitentning balans qiymati statistikasi:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Helius Medical|HSDT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Helius Medical Technologies|HSDT - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Helius Medical Technologies, Inc.|HSDT - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzlari Helius Medical Technologies|Tezkor likvidlik heliusmedical.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
HSDT - Sof moliyaviy natija|Prognoz qilingan kelajakdagi foyda Helius Medical|HSDT - Narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati Helius Medical Technologies|HSDT - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Helius Medical Technologies, Inc.|HSDT - Eskirishdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Helius Medical Technologies|HSDT - So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi heliusmedical.com|HSDT - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Helius Medical
- sotuvlar va tushum ko'rsatkichlari:
Kompaniyaning fundamental tahlili:HSDT (Helius Medical Technologies Inc.)
Ushbu ko'rsatkich joriy bozor kapitalizatsiyasining kutilayotgan savdo hajmi nisbati sifatida hisoblanadi, bu esa hisobotlar e'lon qilinishidan oldin aktivlarning haddan tashqari qimmat baholanganligini real vaqt rejimida baholash imkonini beradi. Kelgusidagi narx-savdo nisbatining tahlili sug'urta to'lovlarining murakkabligi va farmakoterapiya raqobati fonida bozor optimizmining darajasini ochib beradi, bunda grafikdagi har qanday keskin ko'tarilish Helius Medical (HSDT) ning neyromodulyatsiya texnologiyalariga nisbatan shishirilgan kutuvlar haqida signal beradi.
Helius Medical kimlar bilan raqobatlashadi
Narxning prognoz qilingan daromadga nisbati Biogen BIIB|NBIX - Forvard narx/daromad multiplikatori|Regencell - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Axsome Corp|ACAD: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati XENE|VKTX (Viking Therapeutics, Inc.) - Forvard P/S multiplikatori|Supernus Pharmaceuticals, Inc. (SUPN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori CPRX|Forvard narx/daromad multiplikatori Denali Corp DNLI|Forvard P/S multiplikatori HRMY (Harmony Biosciences)|Forvard P/S multiplikatori biohavenpharma.com BHVN|AMLX - Narxning prognoz qilingan daromadga nisbati|TRVI: Narxning prognoz qilingan daromadga nisbati|PRAX: Forvard P/S multiplikatori|Anavex Life Sciences Corp - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati CeriBell, Inc.|Prothena Corporation (PRTA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori ALEC|Annexon Biosciences - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Omeros - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati NGNE (Neurogene Therapeutics)|ACIU - Narxning prognoz qilingan daromadga nisbati|VYGR (voyagertherapeutics.com) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|NMRA: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Scilex Holding (SCLX)|Forvard narx/daromad multiplikatori TVGN|Forvard P/S multiplikatori Alpha Cognition Corp|Narxning prognoz qilingan daromadga nisbati Cognition Therapeutics (CGTX)|IKT (inhibikase.com) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Cassava Sciences SAVA|Assertio Holdings (ASRT) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Coya - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx VTGN (Vistagen Therapeutics)|OVID: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati acumenpharm.com (ABOS)|Narxning prognoz qilingan daromadga nisbati CervoMed|Narxning prognoz qilingan daromadga nisbati ATHE|Forvard P/S multiplikatori CLNN|Kapitalizatsiyaning kutilayotgan sotuvga nisbati pepgen.com|Jupiter Neurosciences Inc - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori relmada.com RLMD|ANVS - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Grace Therapeutics, Inc. GRCE|AIFF (Firefly Neuroscience Inc) - Forvard narx/daromad multiplikatori|Klotho Neurosciences - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati NeuroSense Therapeutics Ltd|Forvard narx/daromad multiplikatori revivapharma.com (RVPH)|Forvard P/S multiplikatori MTVA|NRXS - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori PASG (Passage Bio)|NEUP: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Minerva Neurosciences - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati athira.com ATHA|ADXN: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Alzamend Neuro|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Protagenic|Narxning prognoz qilingan daromadga nisbati Pasithea Therapeutics (KTTA)|Narxning prognoz qilingan daromadga nisbati CRGT (cortigent.com)|Forvard P/S multiplikatori ATXI (Avenue Therapeutics, Inc.)|Sotuvga nisbatan forvard narx BCLI|CARA - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Chromocell CHRO|ELYM: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ITCI|Forvard narx/daromad multiplikatori LBPH|MRNS (Marinus Pharmaceuticals Inc) - Narxning kutilayotgan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati NKGen (NKGN)|NeuroBo Pharma - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori SAGE (Sage Therapeutics, Inc.)|synaptogen.com (SNPX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|TRVN: Forvard narx/daromad multiplikatori|VIGL - Forvard P/S multiplikatori|Anew Medical (WENA) - Narxning prognoz qilingan daromadga nisbati|Cerevel Corp - Sotuvga nisbatan forvard narx
